SCHEMBL6935492

SCHEMBL6935492

COC(=O)C(=NOC(C)(C)C)c1ccc(C)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.46
ALDH1A1 P00352 8/20 0.44
MAPT P10636 4/20 0.44
KDM4E B2RXH2 1/20 0.44
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
GAA P10253 1/20 0.39
CES2 O00748 2/20 0.38
CES1 P23141 2/20 0.38
LMNA P02545 2/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ACHE P22303 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
HPGD P15428 2/20 0.36
MMP13 P45452 1/20 0.36
RXRA P19793 1/20 0.35
RXRB P28702 1/20 0.35
RXRG P48443 1/20 0.35
PKM P14618 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6932293 0.85 TSHR (0.44) TDP1ALDH1A1MAPTRAB9AGAA
SCHEMBL29172895 0.83 TDP1 (0.52) TDP1ALDH1A1MAPTKDM4ENPC1
SCHEMBL28845729 0.83 TDP1 (0.52) TDP1ALDH1A1MAPTKDM4ENPC1
SCHEMBL6932532 0.82 HDAC8 (0.44) NPC1RAB9AHDAC6SMN1; SMN2ATM
SCHEMBL6935112 0.71 SMN1; SMN2 (0.43) TDP1ALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL6934148 0.71 L3MBTL1 (0.43) ALDH1A1MAPTNPC1RAB9AGAA
SCHEMBL6932501 0.71 PKM (0.47) TDP1ALDH1A1MAPTKDM4ENPC1
SCHEMBL6934141 0.71 CYP2D6 (0.43) TDP1ALDH1A1MAPTLMNASMN1; SMN2
SCHEMBL1685862 0.70 MAOB (0.59) ALDH1A1MAPTNPC1RAB9ALMNA
SCHEMBL9043211 0.69 CA1 (0.52) ALDH1A1MAPTGAALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200393-B1 OXIME AMIDES AND HYDRAZONE AMIDES HAVING FUNGICIDAL ACTIVITY MONSANTO TECHNOLOGY LLC (US) 2003-12-10 EP disclosed
EP-1200393-A1 OXIME AMIDES AND HYDRAZONE AMIDES HAVING FUNGICIDAL ACTIVITY Monsanto Technology LLC (US) 2002-05-02 EP disclosed
US-20020045655-A1 Oxime amides and hydrazone amides having fungicidal activity MONSANTO TECHNOLOGY LLC. 2002-04-18 US disclosed
US-6359156-B1 CONTROLLING DISEASES IN CEREAL PLANTS MONSANTO TECHNOLOGY LLC 2002-03-19 US disclosed
US-6297271-B1 CONTROLLING TAKE-ALL DISEASE IN A PLANT MONSANTO TECHNOLOGY LLC 2001-10-02 US disclosed
WO-2001012590-A1 OXYME AMIDES AND HYDRAZONE AMIDES HAVING FUNGICIDAL ACTIVITY MONSANTO TECHNOLOGY LLC (US) 2001-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020045655-A1 Oxime amides and hydrazone amides having fungicidal activity AADAC, HAAO, OGA TDP1 2011/4885ALDH1A1 1260/4885MAPT 3063/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.